Home
Genequest

Genequest Market Share Analysis for October 2026

Genequest：特定商取引に関する表示です。

Business and Consumer Services > Marketing and Advertising

Domaingenequest.jp

Year Founded--

Employees51 - 200

Annual Revenue--

Genequest

Genequest (including company regionals)

genequest.jp

See more website traffic and engagement information

Total visits to Genequest's top domains

Understand Genequest market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

genequest.jp32.8K

See more with Sales Intelligence

Avg. visit duration in Genequest's top domains

Analyze Genequest engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

genequest.jp00:02:39

See more with Sales Intelligence

Avg. pageviews on Genequest's top domains

See how Genequest keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

genequest.jp5.90

See more with Sales Intelligence

Genequest top competitors by domain

Top similar sites in October 2026, ranked by their affinity

genomind.comCompany NameGenomindEmployees51 - 200HQUnited States, Pennsylvania, King of PrussiaAnnual revenue$25M - $50MTotal visits44.1KHealth > Mental Health

Top technologies used by Genequest

These are the website technologies, by industry, used by Genequest top domains

Advertising (18)

Google Adsense

Conversion & Analytics (7)

Google Analytics

Payment & Currencies (6)

Visa

Social (5)

Facebook Connect

More Technologies

8

See all

News & Signals from Genequest

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGenequest Inc. is developing patient registry for inflammatory bowel disease3H Medi Solution and Genequest are collaborating to establish a patient registry for inflammatory bowel disease (IBD).

NewsReqMed Company partnered with Genequest Inc. on Jan 1st '20For instance, in January 2020, ReqMed entered into an exclusive collaboration agreement with Japan’s GeneQuest for the development of new therapies for obstructive hypertrophic cardiomyopathy (HCM).